Hematologic Malignancy (Leukemia/Lymphoma)

Overview
Contact Us
Our Providers

Hematologic Malignancy (Leukemia/Lymphoma)

The Hematological Malignancy Program consists of a multidisciplinary team focused on the prevention, diagnosis, and treatment of cancers arising in the bone marrow, lymph nodes and other associated organs. The program is also focused on the education of students, residents and fellows who will be conducting scholarly and peer-reviewed clinical, translational and basic research in hematological malignancies.

The Hematological Malignancy Program has several “state of the art” basic, translational and clinical research programs in Acute Leukemias, Non-Hodgkin Lymphoma, Hodgkin Lymphoma and other associated hematological malignancies. Overall the program is equipped to design and deliver customized and personalized therapy for each child and adolescent in the cancer center diagnosed with a hematological malignancy.

Diseases We Treat

Acute Lymphoblastic Leukemia (ALL) [Our Clinical Trials, Patient Information]
Acute Myelogenous Leukemia (AML) [Our Clinical Trials, Patient Information]
Juvenile Myelomonocytic Leukemia (JMML) [Our Clinical Trials, Patient Information]
Chronic Myelogenous Leukemia (CML) [Our Clinical Trials, Patient Information]
Non-Hodgkin Lymphoma, including Burkitt Lymphoma/Leukemia [Our Clinical Trials, Patient Information]
- Diffuse Large B-Cell Lymphoma
- Lymphoblastic Lymphoma
- Primary Mediastinal B-Cell Lymphoma
- Anaplastic Large Cell Lymphoma
- Peripheral T-Cell Lymphoma
- NK Cell Lymphoma
Hodgkin Lymphoma [Our Clinical Trials, Patient Information]

Unique Features:

Cutting edge customized patient treatment protocols
Ten protective isolation hospital rooms for induction therapy and stem cell transplantation
Outpatient Infusion Center for patient specific therapies
State of the Art Diagnostic Laboratories
Local and total body radiation facilities
Targeted and developmental Therapeutics
Monoclonal antibody and radio-conjugate antibody therapies
Comprehensive Stem and Cellular Therapy and Transplantation Program
Cellular and Tissue Engineering Laboratory
Multidisciplinary team

Research and Education Highlights:

ACGME Accredited Pediatric Hematology, Oncology and Stem Cell Transplantation Fellowship Training Program
Student, resident and other allied health professional elective/selectives
Children’s Oncology Group (COG) Member Institution
Childhood, Adolescent and Young Adult Lymphoma Cell Therapy Consortium (LCTC), Lead Institution
Childhood, Adolescent and Young Adult Non Hodgkins Lymphoma Translational Research and Treatment
Consortium, Lead Institute
Stem Cell Transplantation for Poor Risk Acute Leukemia Consortium, Lead Institution
Pediatric Blood and Marrow Transplant Consortium (PBMTC), Member Institution
National Marrow Donor Program (NMDP), Member Institution
Leukemia and Lymphoma Cancer Genetics Research Program
Leukemia and Lymphoma Tumor Immunology and Cellular Therapeutics Research Program

Pediatric Hematology/Oncology
Maria Fareri Children’s Hospital
100 Woods Road
Valhalla, NY 10595
914.493.7997

By Car

Train

Maria Fareri Children’s Hospital is served by Metro North's Harlem line via two stations:

• White Plains - Bus transfer options available
• Hawthorne - Taxi service available

For train fare and schedule information, call 1-800-METRO-INFO or go to METRO NORTH